Athletic Training and Arrhythmogenic Right Ventricular Cardiomyopathy
Sara Alcobia Coelho1,2, Filipe Silva2, Joana Silva1,2
1ACeS Baixo Mondego, USF Mondego, Coimbra, Portugal.
International Journal of Sports Medicine
|March 14, 2019
Summary
Distinguishing arrhythmogenic right ventricular cardiomyopathy (ARVC) from athlete's heart is crucial. Intense exercise can trigger ARVC symptoms even without a known genetic link, complicating diagnosis and sports eligibility.
Area of Science:
- Cardiology
- Sports Medicine
- Genetics
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited condition causing ventricular arrhythmias and sudden death, particularly in young individuals and athletes.
- Intense physical exercise is known to worsen ARVC outcomes, but can also mimic its early signs in healthy athletes.
- The overlap between athlete's heart adaptations and ARVC pathology presents diagnostic challenges.
Purpose of the Study:
- To delineate the key differences between athlete's heart and ARVC.
- To review diagnostic tools aiding in the differential diagnosis of these conditions.
- To clarify sports eligibility implications for individuals with suspected ARVC.
Main Methods:
- Literature review focusing on distinguishing features of ARVC and athlete's heart.
- Analysis of diagnostic criteria and imaging findings.
- Evaluation of exercise's role in ARVC progression and athlete cardiac adaptation.
Main Results:
- Significant overlap exists between physiological cardiac changes in athletes and pathological findings in ARVC.
- Specific imaging and electrocardiographic features can help differentiate the two conditions.
- Exercise can unmask or exacerbate ARVC, even in individuals without a clear genetic predisposition.
Conclusions:
- Differentiating ARVC from athlete's heart requires careful clinical evaluation, considering genetic history, imaging, and electrophysiological data.
- Exercise recommendations must be individualized based on the diagnosis to prevent adverse outcomes.
- Clear guidelines are needed for sports participation in athletes with potential ARVC.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
465
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
465
Cardiomyopathy II: Dilated Cardiomyopathy
548
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
548
Cardiomyopathy IV: Restrictive Cardiomyopathy
512
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
512
Cardiomyopathy V: Interprofessional Care
390
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
390
Cardiomyopathy I: Introduction and Classification
580
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
580
Cardiomyopathy VI: Nursing Management
344
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
344


